inflamm
promin
featur
sever
disord
character
primari
demyelin
clear
whether
relationship
exist
inflamm
myelin
damag
found
substanti
demyelin
result
focal
inflammatori
lesion
caus
inject
lipopolysaccharid
lp
ng
directli
rat
dorsal
funiculu
within
h
inject
caus
focal
inflammatori
respons
consist
substanti
number
polymorphonuclear
cell
induc
nitric
oxid
synthas
ino
posit
macrophagesmicroglia
number
inflammatori
cell
substanti
reduc
day
tcell
less
frequent
observ
present
mening
h
reach
maximum
dorsal
funiculu
day
rare
day
inflamm
follow
appear
larg
lesion
primari
demyelin
encompass
crosssect
area
dorsal
funiculu
treatment
dexamethason
significantli
reduc
number
cell
express
ino
prevent
demyelin
day
lesion
larg
remyelin
usual
schwann
cell
chang
observ
control
salineinject
anim
conclud
intraspin
inject
lp
result
inflamm
subsequ
promin
demyelin
mechan
underli
demyelin
clear
notabl
typic
begin
disrupt
adaxon
myelin
inde
earli
loss
myelinassoci
glycoprotein
within
lesion
despit
persist
proteolipid
protein
combin
featur
pattern
iii
lesion
recent
describ
multipl
sclerosi
lucchinetti
et
al
therefor
suggest
lpsinduc
demyelin
may
serv
first
experiment
model
avail
studi
type
multipl
sclerosi
lesion
abbrevi
adpc
adenomat
polyposi
coli
gfap
glial
fibrillari
acid
protein
intercellular
adhes
ino
induc
form
nitric
oxid
synthas
lp
lipopolysaccharid
mag
myelinassoci
glycoprotein
pb
phosphatebuff
salin
plp
proteolipid
protein
pmn
polymorphonuclear
cell
inflamm
within
cn
common
featur
neurolog
disord
infect
whether
contribut
directli
neuron
glial
damag
vivo
difficult
determin
exampl
diseas
multipl
sclerosi
anim
model
experiment
autoimmun
encephalomyel
eae
immunemedi
inflamm
promin
difficult
disentangl
indirect
consequ
inflamm
ongo
immunemedi
diseas
process
experiment
inflamm
induc
tissu
local
inject
lipopolysaccharid
lp
typic
larg
number
neutrophil
monocyt
invad
tissu
bloodstream
within
minut
macrophag
remain
site
number
day
issekutz
et
al
cybulski
et
al
howev
lp
inject
parenchyma
adult
brain
result
alter
attenu
cellular
respons
thu
quantiti
lp
elicit
typic
inflammatori
respons
skin
ng
result
author
publish
oxford
univers
press
behalf
guarantor
brain
right
reserv
permiss
pleas
email
journalspermiss
oupjournalsorg
recruit
either
neutrophil
monocyt
examin
day
inject
hippocampu
andersson
et
al
cellular
influx
attenu
despit
fact
ng
lp
effect
rapidli
upregul
express
endotheli
intercellular
adhes
vascular
celladhes
molecul
vcam
bell
perri
proinflammatori
cytokin
interleukin
tumour
necrosi
factor
tnfa
stern
et
al
increas
quantiti
lp
inject
ng
result
florid
extravas
neutrophil
skin
still
result
signific
neutrophil
recruit
brain
parenchyma
although
caus
activ
microglia
recruit
monocyt
andersson
et
al
monteromenei
et
al
studi
consequ
lpsinduc
inflamm
brain
far
tend
focu
rel
acut
effect
use
highresolut
histolog
techniqu
assess
chang
tissu
architectur
moreov
studi
far
neglect
inject
lp
spinal
cord
despit
observ
inflammatori
respons
differ
brain
spinal
cord
follow
traumat
lesion
schnell
et
al
therefor
examin
detail
shortand
longterm
consequ
inject
lp
spinal
white
matter
studi
use
light
electron
microscopi
immunohistochemistri
examin
tissu
day
inject
order
determin
time
cours
cellular
recruit
chang
local
tissu
structur
report
follow
recruit
neutrophil
macrophag
larg
primari
demyelin
lesion
form
dorsal
funiculu
delay
week
follow
inject
possibl
inflammationassoci
demyelin
observ
studi
may
illumin
mechan
underli
inflammationassoci
demyelin
multipl
sclerosi
particularli
pattern
iii
lesion
use
steril
techniqu
deep
halothan
anaesthesia
quarter
laminectomi
perform
vertebr
level
adult
male
spraguedawley
rat
g
mean
sd
two
small
hole
mm
apart
made
dura
left
dorsal
column
drawn
glass
micropipett
typic
extern
tip
diamet
mm
insert
dorsal
column
ml
lp
ngml
salin
inject
two
site
depth
mm
ml
total
inject
site
mark
place
small
amount
steril
charcoal
adjac
dura
control
anim
receiv
inject
salin
alon
lesion
site
mark
way
lp
salmonella
abortu
equi
typhimurium
escherichia
coli
serotyp
sigma
gillingham
dorset
uk
catalogu
number
respect
use
without
purif
endotoxin
activ
commerci
obtain
lp
estim
semiquantit
dilut
method
use
limulu
amoebocyt
lysat
assay
etox
kit
sigma
one
set
experi
highli
purifi
lp
abortu
equi
alexi
biochem
nottingham
uk
catalogu
number
use
determin
lesion
result
inject
contamin
known
present
mani
less
highli
purifi
commerci
prepar
lp
anim
perfus
via
left
ventricl
deep
halothan
anaesthesia
follow
time
lpsinject
anim
perfus
h
n
day
n
day
n
day
n
day
n
day
n
unpurifi
lp
n
purifi
lp
day
n
day
n
salineinject
anim
perfus
h
n
h
n
day
n
day
n
day
n
vasculatur
rins
approxim
ml
normal
salin
contain
ul
heparin
lignocain
nano
acid
hepe
ph
follow
approxim
ml
glutaraldehyd
phosphat
buffer
ph
pressur
head
cm
tissu
cut
transvers
mm
thick
block
postfix
osmium
tetroxid
phosphat
buffer
dehydr
grade
alcohol
pass
propylen
oxid
embed
taab
resin
taab
laboratori
aldermaston
uk
light
microscopi
mm
thick
section
cut
ultramicrotom
stain
toluidin
blue
examin
photograph
use
zeiss
axiophot
microscop
equip
jvc
frame
captur
camera
electron
microscopi
nm
thick
section
stain
uranyl
acet
lead
citrat
examin
hitachi
transmiss
electron
microscop
anim
whose
tissu
examin
immunohistochemistri
perfus
postinject
time
h
day
time
point
n
lpsinject
anim
n
salineinject
anim
six
addit
anim
two
lpsinject
one
salineinject
h
inject
perfus
specif
examin
express
induc
form
nitric
oxid
synthas
ino
shortterm
lesion
addit
one
naiv
anim
also
perfus
obtain
normal
tissu
method
except
fix
consist
freshli
prepar
paraformaldehyd
phosphat
buffer
follow
perfus
spinal
cord
either
cryoprotect
immers
sucros
h
embed
oct
compound
bdh
pool
uk
frozen
store
use
c
process
polyest
wax
use
standard
techniqu
kent
frozen
section
mm
cut
use
cryostat
float
phosphatebuff
salin
pb
immunohistochem
label
polyest
wax
section
mm
cut
microtom
equip
peltiercool
chuck
float
gelatin
solut
attach
slide
apart
anatom
landmark
dural
scar
presenc
charcoal
surfac
spinal
cord
confirm
inject
site
immunohistochem
label
use
identifi
cell
type
examin
express
adhes
molecul
inflammatori
factor
myelin
protein
peroxidas
fluoresc
report
use
experi
use
peroxidas
section
incub
pb
contain
azid
h
min
follow
nonimmun
rat
serum
sigma
min
tissu
incub
primari
antibodi
dilut
except
note
includ
pb
bovin
serum
albumin
rat
serum
overnight
c
follow
thorough
wash
incub
room
temperatur
h
horseradish
peroxidaseconjug
rat
antimous
f
ab
fragment
secondari
antibodi
dilut
jackson
immunoresearch
laboratori
west
grove
pa
follow
thorough
wash
immunolabel
visual
diaminobenzidin
dab
substrat
kit
vector
laboratori
peterborough
uk
section
mount
slide
dehydr
grade
ethanol
clear
xylen
mount
styrolit
bdh
pool
uk
experi
use
fluoresc
label
section
incub
primari
antibodi
solut
includ
normal
goat
serum
overnight
c
thorough
wash
section
incub
h
room
temperatur
appropri
goat
antirabbit
goat
antimous
f
ab
fragment
secondari
antibodi
conjug
fluorescein
rhodamin
dilut
chemicon
harrow
uk
inflammatori
cell
identifi
use
monoclon
primari
antibodi
mrc
serotec
kidlington
uk
dilut
recogn
lymphocyt
macrophagesactiv
microglia
b
lymphocyt
respect
oligodendrocyt
label
monoclon
antibodi
clone
rais
fragment
adenomat
polyposi
coli
adpc
protein
bhat
et
al
polyest
wax
section
oncogen
research
product
san
diego
ca
usa
dilut
monoclon
antibodi
also
use
demonstr
presenc
ino
dilut
clone
affin
research
product
exet
uk
dilut
clone
gift
prof
david
male
open
univers
uk
serotec
clone
silk
polyclon
antibodi
recogn
serotec
use
doublelabel
experi
cell
type
express
investig
use
fluoresc
doublelabel
monoclon
primari
antibodi
macrophag
rest
microglia
serotec
astrocyt
glial
fibrillari
acid
protein
gfap
sigma
express
myelin
compon
proteolipid
protein
plp
myelinassoci
glycoprotein
mag
within
lp
lesion
examin
polyest
wax
section
doublelabel
rabbit
polyclon
antimag
antibodi
rais
peptid
locat
carboxi
termin
lmag
butt
et
al
dilut
rhodamin
conjug
secondari
monoclon
antiplp
serotec
dilut
fluorescein
conjug
secondari
antibodi
cell
label
count
use
object
transvers
section
spinal
cord
near
centr
lesion
singl
valu
anim
deriv
sever
region
spinal
cord
eg
dorsal
funiculu
later
column
tabl
averag
count
three
nonadjac
transvers
section
polymorphonuclear
cell
pmn
identifi
resin
section
multilobular
nuclear
morpholog
cell
type
examin
extravas
cell
includ
thu
label
cell
within
vascular
lumen
exclud
fluoresc
adpcposit
cell
count
dorsal
funiculu
anim
inject
salin
n
lp
n
day
inject
interv
lesion
clearli
discern
use
differenti
interfer
contrast
optic
region
tissu
disrupt
dorsal
funiculu
allow
adpcposit
cell
count
demyelin
appar
normal
area
dorsal
funiculu
lpsinject
anim
adpcposit
cell
count
montag
digit
imag
captur
use
object
order
examin
effect
broadspectrum
antiinflammatori
agent
lpsinduc
demyelin
daili
intraperiton
inject
either
dexamethason
mgkg
n
salin
n
given
anim
begin
day
prior
inject
lp
dorsal
funiculu
determin
extent
suppress
inflammatori
respons
three
anim
treatment
group
reanaesthet
perfus
paraformaldehyd
phosphat
buffer
day
lp
inject
spinal
cord
inject
site
frozen
examin
ino
express
immunohistochemistri
use
polyclon
rabbit
antino
primari
antibodi
transduct
laboratori
oxford
uk
dilut
section
subsequ
photograph
use
digit
camera
spot
rt
label
cell
within
dorsal
funiculu
count
determin
consequ
dexamethason
treatment
extent
demyelin
remain
four
anim
treatment
group
perfus
day
lp
inject
glutaraldehyd
phosphat
buffer
tissu
process
light
electron
microscopi
crosssect
area
lesion
within
dorsal
funiculu
measur
digit
photograph
use
imag
analysi
program
sigma
scan
lp
lipid
carbohydr
moieti
like
exhibit
detergentlik
properti
could
solubil
cell
membran
lead
demyelin
assess
whether
properti
might
confus
find
abil
lp
directli
attack
cell
membran
assess
erythrocyt
lysi
assay
use
deterg
sodium
dodecyl
sulphat
sd
lysophosphatidylcholin
comparison
erythrocyt
suspend
isoton
salin
expos
lp
deterg
min
room
temperatur
suspens
centrifug
haemoglobin
releas
assess
measur
absorb
nm
salmonella
typhimurium
lp
stock
solut
dilut
mgml
carbon
buffer
ml
ad
well
immulon
elisa
plate
left
overnight
c
wash
block
ml
fish
gelatin
sigma
pb
h
c
rat
sera
collect
n
n
n
n
n
day
lp
inject
sera
dilut
bovin
serum
albumin
bsa
pb
ml
ad
well
overnight
c
second
antibodi
alkalin
phosphataseconjug
antirat
sigma
ad
h
c
substrat
develop
h
c
optic
densiti
read
nm
linbro
enzym
immunoassay
eia
plate
coat
ml
rat
cn
myelin
mg
protein
per
ml
methylglyox
ph
h
c
plate
care
wash
tween
three
time
block
ml
fish
gelatinepb
h
c
rat
sera
collect
n
n
n
day
lp
inject
dilut
bsapb
ml
ad
well
well
incub
overnight
c
plate
wash
care
three
time
pbstween
ad
alkalin
phosphatas
conjug
antirat
immunoglobulin
g
h
c
wash
three
time
plate
develop
pnitrophenol
optic
densiti
read
nm
prior
exposur
pathogen
could
influenc
reaction
anim
lp
inject
one
group
experi
monitor
anim
number
infecti
agent
surveil
anim
hous
room
experiment
anim
return
supplier
harlan
uk
loughborough
uk
routin
pathogen
screen
inject
lp
result
earli
invas
inflammatori
cell
parenchyma
spinal
cord
invas
limit
dorsal
funiculu
initi
associ
appar
damag
nerv
fibr
inject
dorsal
funiculu
howev
day
lp
inject
larg
focal
demyelin
lesion
form
within
dorsal
funiculu
repair
remyelin
commenc
day
day
larg
number
remyelin
axon
present
remyelin
schwann
cell
assay
inject
lp
solut
use
semiquantit
limulu
amoebocyt
lysat
method
yield
follow
endotoxin
activ
abortu
equi
endotoxin
unitsml
typhimurium
endotoxin
unitsml
ecoli
endotoxin
unitsml
lp
deriv
three
bacteria
found
produc
similar
lesion
therefor
consid
togeth
spinal
cord
inject
salin
fig
show
damag
restrict
small
number
axon
undergo
either
tabl
popul
inflammatori
cell
present
spinal
cord
variou
time
follow
inject
lp
salin
dorsal
funiculu
wallerian
degener
demyelin
damag
present
time
period
greater
day
inject
occur
pial
surfac
region
insert
inject
pipett
along
line
inject
pipett
deep
within
dorsal
funiculu
remyelin
axon
observ
salineinject
anim
eight
hour
lp
inject
number
inflammatori
cell
present
within
spinal
cord
see
cell
popul
within
spinal
cord
cord
otherwis
appear
grossli
normal
myelin
sheath
dorsal
funiculu
appear
intact
one
day
lp
inject
day
lp
inject
left
dorsal
column
sign
intens
local
respons
tissu
damag
grey
matter
adjac
deep
portion
left
dorsal
column
tissu
immedi
surround
inject
site
within
dorsal
column
appear
grossli
normal
fig
examin
electron
microscop
reveal
mild
increas
extracellular
space
within
white
matter
howev
widespread
occasion
demyelin
axon
seen
may
associ
needl
trauma
infrequ
debriscontain
monocyt
cell
present
contrast
pmn
numer
close
blood
vessel
within
parenchyma
dorsal
column
particularli
grey
matter
adjac
deep
portion
left
dorsal
column
three
day
lp
inject
light
microscop
spinal
cord
similar
appear
observ
day
inject
includ
obviou
cellular
infiltr
fig
although
white
matter
damag
promin
occasion
demyelin
axon
per
section
observ
larg
number
inflammatori
cell
evid
grey
matter
adjac
deep
portion
left
dorsal
column
cuff
consist
multipl
layer
mononuclear
polymorphonuclear
cell
surround
vessel
region
fig
electron
microscopi
reveal
obviou
oedema
fig
extend
otherwis
normal
adjac
white
matter
expand
extracellular
space
contain
mani
small
process
profil
well
fluidfil
space
appear
aris
damag
axon
electron
microscopi
confirm
presenc
infrequ
demyelin
axon
fig
well
demonstr
mani
myelin
fibr
intern
mesaxon
obviou
endothelium
small
vessel
show
low
densiti
microvilli
show
obviou
sign
activ
ie
hypertrophi
phagocyt
contain
myelin
possibl
axon
debri
found
throughout
lesion
five
day
lp
inject
light
microscopi
indic
cellular
infiltr
reduc
oedema
obviou
fig
expand
extracellular
space
confirm
electron
microscop
found
contain
floccular
materi
presum
precipit
protein
fig
debriscontain
macrophag
promin
particularli
perivascular
space
also
enlarg
withdraw
astrocyt
process
chang
indic
breakdown
bloodbrain
barrier
small
area
nonmyelin
axon
usual
less
mm
calibr
seen
whether
result
demyelin
difficult
determin
seven
day
lp
inject
larg
lesion
present
within
dorsal
funiculu
fig
b
consist
demyelin
axon
commonli
occupi
ventral
half
ventral
twothird
right
left
dorsal
funiculu
includ
restrict
corticospin
tract
characterist
breakdown
myelin
sheath
appear
progress
adaxon
region
outward
cytoplasm
region
schmidtlanterman
incisur
paranod
region
myelin
breakdown
appear
transvers
section
progress
small
vesicular
appear
larger
disorgan
mesh
membran
fig
obliqu
section
small
vesicl
seen
tube
appear
reminisc
seen
earli
stage
lysophosphatidylcholineinduc
demyelin
hall
gregson
demyelin
instanc
appear
take
place
without
close
apposit
myelomonocyt
cell
apoptot
cell
seen
howev
dissolut
nuclear
cytoplasm
compon
difficult
identifi
cell
morpholog
criteria
mani
phagocyt
cell
contain
myelin
debri
seen
extracellular
space
also
contain
consider
amount
membran
myelin
debri
despit
promin
demyelin
axon
loss
indic
number
fibr
undergo
wallerian
degener
small
sensori
ascend
portion
dorsal
column
mm
rostral
lesion
fig
descend
corticospin
tract
mm
caudal
lesion
fig
fourteen
day
lp
inject
light
microscopi
reveal
larg
mix
lesion
contain
demyelin
axon
debrisfil
macrophag
axon
associ
cell
fig
axoncel
associ
often
onetoon
basi
suggest
cell
schwann
cell
enlarg
extracellular
space
remain
electron
microscop
found
contain
membran
debri
examin
electron
microscop
also
provid
convinc
evid
presenc
nake
axon
cell
process
often
identifi
mani
debrisfil
phagocyt
demyelin
axon
encircl
cell
process
common
cell
bodi
ensheath
cell
often
present
plane
section
mani
case
cell
appear
initi
remyelin
twentyeight
day
lp
inject
lesion
repair
remyelin
well
advanc
fig
f
oedema
reduc
mani
fewer
debriscontain
phagocyt
remyelin
accomplish
mixtur
schwann
cell
oligodendrocyt
typic
schwann
cell
remyelin
predomin
core
lesion
small
amount
myelin
membran
debri
present
extracellular
compart
scatter
cystic
vacuol
appear
deriv
dead
axon
present
larger
lesion
area
dorsal
funiculu
appear
enlarg
fig
densiti
myelin
fibr
appear
lower
normal
fig
inflammatori
cell
present
particularli
surround
blood
vessel
grey
matter
immedi
adjac
dorsal
funiculu
one
blood
vessel
outlin
box
b
shown
higher
magnif
c
mononuclear
cell
pmn
seen
wall
vessel
littl
demyelin
present
day
seen
clearli
inset
show
region
within
box
higher
magnif
scale
bar
shown
mm
b
main
imag
mm
c
mm
inset
one
pmn
present
variou
region
within
spinal
cord
examin
h
salin
inject
interv
produc
greatest
number
cell
anim
inject
lp
tabl
mening
surround
spinal
cord
pmn
day
interv
produc
greatest
number
cell
lpsinject
spinal
cord
one
label
cell
observ
salineinject
cord
addit
two
cell
present
mening
also
time
small
number
cell
present
salineinject
spinal
cord
howev
found
either
dorsal
funiculu
mening
cell
dorsal
funiculu
found
extend
line
left
dorsal
column
pial
surfac
presum
result
minor
damag
associ
inject
track
cell
found
mening
associ
particl
charcoal
use
mark
inject
site
follow
lp
inject
invas
spinal
cord
inflammatori
cell
appar
h
earliest
time
point
examin
follow
day
overal
number
inflammatori
cell
present
cell
type
compris
popul
progress
characterist
pattern
describ
follow
paragraph
although
larg
major
axon
myelin
grossli
disrupt
time
small
number
demyelin
axon
arrow
inset
present
lack
myelin
debri
extracellular
space
surround
demyelin
axon
suggest
demyelin
occur
soon
inject
morpholog
similar
day
lp
inject
b
myelin
sheath
fibr
grossli
normal
small
region
cleanli
demyelin
axon
also
present
eg
arrow
inset
howev
day
inject
c
e
sheath
exhibit
enlarg
adaxon
compart
contain
variou
amount
lamellar
debri
common
scale
bar
shown
e
mm
inset
mm
mm
b
inset
mm
mm
c
mm
e
fig
light
micrograph
dorsal
funiculi
day
b
day
c
day
e
f
inject
lp
pair
micrograph
imag
left
show
dorsal
funiculu
adjac
grey
matter
low
magnif
imag
right
show
region
lesion
high
magnif
lowmagnif
micrograph
c
e
margin
dorsal
funiculu
outlin
arrowhead
day
inject
deep
dorsal
funiculu
includ
corticospin
tract
undergo
demyelin
b
show
number
axon
disintegr
myelin
arrow
lamella
separ
either
adaxon
surfac
midsheath
sever
debrisfil
macrophag
eg
arrowhead
b
present
day
inject
similar
region
lesion
present
c
howev
appar
lesion
consist
mainli
either
appar
nake
demyelin
axon
eg
arrow
demyelin
axon
earli
stage
associ
cell
eg
arrowhead
number
debrisfil
phagocyt
obviou
day
inject
larg
lesion
present
occupi
nearli
dorsal
funiculu
time
axon
signet
ring
appear
characterist
schwann
cell
remyelin
predomin
arrow
f
scale
bar
shown
f
mm
c
e
mm
b
f
pmn
eight
hour
inject
pmn
far
numer
either
macrophag
lymphocyt
tabl
given
differ
thick
section
use
count
pmn
versu
use
macrophag
lymphocyt
direct
comparison
made
howev
worth
note
averag
h
pmn
observ
mm
thick
resin
section
macrophag
observ
mm
thick
cryostat
section
h
greatest
number
pmn
present
dorsal
funiculu
mening
although
substanti
number
found
region
particular
grey
matter
h
number
pmn
fallen
approxim
threequart
cell
concentr
dorsal
funiculu
grey
matter
pmn
observ
day
inject
later
macrophag
microglia
cell
tabl
fig
present
spinal
cord
h
lp
inject
approxim
increas
cell
h
h
dorsal
funiculu
account
total
cell
substanti
increas
number
cell
present
dorsal
funiculu
grey
matter
occur
h
day
total
number
cell
fallen
declin
continu
day
day
number
cell
rel
stabl
cell
concentr
within
dorsal
funiculu
lymphocyt
total
number
lymphocyt
within
section
alway
fewer
cell
exhibit
two
peak
tabl
first
smaller
peak
occur
h
inject
cell
associ
mening
neural
parenchyma
inde
prior
day
lymphocyt
observ
within
dorsal
funiculu
second
peak
cell
number
occur
day
inject
fig
mostli
result
cell
within
dorsal
funiculu
day
number
lymphocyt
fallen
near
zero
remain
case
day
b
lymphocyt
cell
observ
spinal
cord
time
lp
inject
oligodendrocyt
significantli
fewer
adpcposit
cell
present
within
lesion
region
dorsal
funiculu
day
lp
inject
cellsmm
mean
sd
either
adjac
unles
region
dorsal
funiculu
anim
cellsmm
one
way
anova
studentnewmankeul
posttest
p
dorsal
funiculu
salineinject
control
anim
cellsmm
p
astrocyt
gfapposit
stellat
processbear
cell
cell
process
present
lpsinject
dorsal
funiculu
h
day
inject
increas
label
intens
process
thick
present
day
inject
increas
gfap
immunoreact
within
grey
matter
directli
adjac
lpsinject
dorsal
funiculu
fig
increas
label
adjac
grey
matter
persist
day
time
nearli
entir
lesion
area
fine
meshwork
moder
gfapimmunoreact
process
occasion
thicker
intens
label
process
present
entir
lesion
area
remain
moder
gfapposit
day
lp
inject
time
exhibit
cobbl
appear
occasion
intens
label
process
present
appear
confin
peripheri
lesion
lesion
remyelin
predomin
schwann
cell
prior
myelin
express
gfap
jessen
et
al
thu
seem
like
moder
label
present
across
lesion
day
repres
label
gfap
within
schwann
cell
prior
immedi
myelin
disappear
astrocyt
schwann
cell
territori
would
predict
previou
studi
region
schwann
cell
remyelin
cn
blakemor
felt
smith
small
number
inosimmunolabel
cell
observ
within
dorsal
funiculu
adjac
grey
matter
earli
h
lp
inject
howev
promin
ino
immunolabel
observ
h
lp
inject
thereaft
declin
small
number
inosposit
cell
observ
day
none
present
day
inject
naiv
spinal
cord
spinal
cord
taken
cm
rostral
site
lp
inject
exhibit
light
label
larger
blood
vessel
fig
lp
inject
markedli
increas
label
h
lp
inject
label
increas
number
label
vessel
appar
intens
label
fig
increas
label
also
observ
day
lp
inject
addit
label
blood
vessel
also
observ
two
popul
cell
lpsinject
dorsal
funiculu
one
group
round
cell
often
close
associ
blood
vessel
tabl
upregul
blood
vessel
evid
site
lp
inject
within
dorsal
funiculu
h
inject
c
compar
light
label
present
dorsal
funiculu
anim
cm
rostral
site
inject
intens
blood
vessel
label
naiv
spinal
cord
similar
shown
data
shown
scale
bar
shown
mm
second
number
cell
ramifi
process
scatter
throughout
parenchyma
dorsal
funiculu
popul
present
rel
small
number
former
observ
day
inject
second
day
inject
label
cell
present
sinc
varieti
cell
like
present
lp
lesion
report
upregul
express
respons
inflammatori
mediat
includ
microglia
zielasek
et
al
macrophag
goebel
et
al
astrocyt
oligodendrocyt
satoh
et
al
like
sever
cell
type
contribut
observ
label
substanti
number
cell
present
across
whole
crosssect
spinal
cord
h
lp
inject
fig
compar
express
h
inject
examin
parallel
studi
data
shown
posit
cell
concentr
adjac
dorsal
funiculu
label
cell
appear
numer
widespread
h
addit
morpholog
cell
differ
somewhat
h
ramifi
cell
round
cell
common
h
ramifi
cell
predomin
h
two
popul
cell
also
present
h
lp
inject
round
cell
locat
throughout
dorsal
funiculu
adjac
grey
matter
wherea
cell
short
stubbi
process
found
distanc
dorsal
funiculu
h
fewer
cell
present
compar
h
exhibit
round
morpholog
week
small
number
cell
present
cell
often
adjac
larg
blood
vessel
form
small
subset
substanti
popul
fig
light
micrograph
show
gfap
immunoreact
interfac
dorsal
funiculu
df
grey
matter
gm
anim
day
inject
lp
spinal
cord
transvers
section
cm
rostral
inject
site
shown
similar
region
site
lp
inject
shown
b
note
fine
label
astrocyt
process
present
site
distant
lesion
dorsal
funiculu
arrow
grey
matter
arrowhead
label
astrocyt
increas
inject
site
thicken
astrocyt
process
dorsal
funiculu
arrow
b
grey
matter
arrowhead
b
overal
increas
label
densiti
grey
matter
scale
bar
mm
plp
mag
immunoreact
examin
doublelabel
section
lp
lesion
induc
day
earlier
three
day
inject
obviou
loss
either
myelin
protein
within
inject
dorsal
funiculu
compar
whitematt
region
section
howev
day
inject
immunoreact
mag
plp
reduc
deep
dorsal
funiculu
typic
site
develop
lpsinduc
demyelin
lesion
fig
b
differenti
loss
mag
site
lp
inject
even
pronounc
day
inject
fig
time
faint
mag
label
observ
within
deep
dorsal
funiculu
fig
compar
immunoreact
present
superfici
dorsal
column
fig
plp
immunoreact
decreas
lesion
compar
fig
g
inde
plp
label
appear
slightli
intens
region
possibl
due
increas
antigen
avail
produc
myelin
disrupt
treatment
dexamethason
effect
reduc
magnitud
inflammatori
respons
fig
b
indic
signific
reduct
averag
number
cell
express
ino
transvers
section
dorsal
funiculu
site
lp
inject
mean
sd
dexamethasonetr
anim
day
lp
inject
versu
cell
salinetr
anim
p
student
ttest
howev
dexamethason
treatment
reduc
extent
lpsinduc
demyelin
spinal
cord
fig
examin
day
lp
inject
averag
crosssect
area
demyelin
dorsal
funiculu
anim
treat
dexamethason
mm
actual
greater
anim
treat
salin
mm
although
differ
statist
signific
p
student
ttest
day
lp
inject
axon
lesion
dexamethasonetr
anim
tend
surround
whorl
myelin
debri
wherea
nake
demyelin
axon
demyelin
axon
associ
cell
process
particularli
common
lp
lesion
salinetr
anim
dexamethasonetr
anim
seemingli
increas
size
lesion
might
due
expans
area
due
physic
bulk
increas
amount
myelin
debri
lesion
examin
day
inject
highli
purifi
lp
prepar
dorsal
funiculu
three
anim
examin
lp
prepar
produc
lesion
fig
similar
seen
unpurifi
lp
prepar
caus
lesion
occupi
crosssect
area
dorsal
funiculu
sera
examin
one
appear
titrat
antilp
antibodi
sampl
singl
anim
day
lp
inject
otherwis
indic
immun
respons
develop
lp
sera
examin
show
reactiv
myelin
low
dilut
indic
increas
reactiv
follow
lp
inject
erythrocyt
lysi
increas
min
exposur
lp
even
concentr
approxim
higher
concentr
inject
spinal
cord
studi
data
shown
contrast
lysophosphatidylcholin
sd
caus
substanti
erythrocyt
lysi
concentr
examin
surveil
anim
supplier
reveal
anim
posit
coronaviru
rat
parvoviru
hantaviru
sendai
viru
theiler
murin
encephalomyel
viru
kilham
rat
viru
toolan
viru
pneumonia
viru
mice
reoviru
lymphocyt
choriomening
viru
anim
also
free
bordetella
bronchiseptica
clostridium
piliform
corynebacterium
kutscheri
mycoplasma
speci
salmonella
speci
streptobacillu
moniliformi
bhaemolyt
streptococci
streptococcu
pneumonia
twothird
anim
test
posit
pasteurella
pneumotropica
respons
anim
lp
inject
dorsal
funiculu
seri
n
similar
observ
experi
describ
inflammatori
demyelin
lesion
aris
follow
inject
lp
rat
spinal
white
matter
substanti
number
pmn
cell
appear
within
white
matter
adjac
spinal
region
within
h
lp
inject
reach
peak
within
first
day
declin
thereaft
earli
phase
lesion
centr
greywhit
matter
border
myelin
sheath
dorsal
funiculu
intact
howev
delay
day
larg
demyelin
lesion
develop
persist
day
often
affect
crosssect
area
dorsal
funiculu
inject
site
demyelin
primari
rel
littl
wallerian
degener
rostral
sensori
cf
show
light
electron
micrograph
lesion
dexamethasonetr
c
e
respect
salinetr
f
respect
anim
day
lp
inject
salinetr
anim
exhibit
lesion
similar
untreat
anim
nest
pack
demyelin
axon
eg
arrow
f
cellassoci
demyelin
axon
eg
arrowhead
rel
small
amount
extracellular
myelin
debri
present
time
eg
upper
left
corner
f
dexamethason
treatment
prevent
demyelin
prolong
presenc
debri
axon
appear
surround
whorl
disaggreg
myelin
eg
arrow
c
e
compar
c
clear
debrisfil
macrophag
eg
promin
lesion
anim
treat
salin
treat
dexamethason
scale
bar
shown
f
mm
b
mm
c
mm
e
f
portion
dorsal
funiculu
caudal
corticospin
tract
inject
site
oligodendrocyt
number
appear
reduc
region
demyelin
howev
possibl
cell
surviv
lose
antigen
react
adpc
antibodi
discount
number
studi
examin
effect
inject
inflammogen
cn
includ
lp
andersson
et
al
bell
perri
stern
et
al
andersson
et
al
minghetti
et
al
schnell
et
al
bernardessilva
et
al
tnfa
andersson
et
al
minghetti
et
al
schnell
et
al
hall
et
al
interferon
g
minghetti
et
al
typic
inflammatori
reaction
evok
cn
substanti
mute
compar
similar
inject
tissu
andersson
et
al
gener
littl
demyelin
report
although
demyelin
specif
examin
studi
two
studi
myelin
examin
limit
myelin
loss
report
matyszak
perri
found
inject
kill
bacillu
bcg
directli
hippocampu
produc
acut
inflammatori
respons
result
myelin
loss
howev
anim
subsequ
given
bcg
peripher
delayedtyp
hypersensit
develop
associ
myelin
loss
assess
immunohistochemistri
subsequ
studi
matyszak
et
al
demonstr
least
small
pocket
myelin
loss
result
primari
demyelin
lehnardt
colleagu
found
reduct
immunolabel
oligodendrocyt
marker
rip
follow
larg
dose
lp
mg
inject
pericallos
white
matter
neonat
rat
lehnardt
et
al
howev
dose
lp
produc
destruct
cystic
lesion
mani
anim
although
natur
myelin
loss
examin
detail
seem
like
secondari
axon
degener
summari
present
studi
first
report
substanti
primari
demyelin
result
directli
inject
inflammogen
cn
mechan
demyelin
follow
inject
lp
dorsal
funiculu
known
sever
possibl
consid
lp
amphiphil
compound
could
display
detergentlik
properti
might
directli
solubil
oligodendrocyt
membran
howev
two
line
evid
argu
mechan
first
use
erythrocyt
lysi
assay
found
evid
membran
damag
secondli
perhap
compellingli
deterg
effect
would
expect
occur
rel
promptli
cf
lysophosphatidylcholineinduc
demyelin
hall
gregson
howev
delay
nearli
week
inject
lp
appear
signific
demyelin
also
possibl
lpsinduc
inflamm
activ
latent
viral
infect
lead
destruct
oligodendrocyt
demyelin
certain
virus
exampl
neurotrop
coronavirus
theiler
viru
caus
demyelin
within
cn
review
see
fazakerli
walker
howev
serolog
screen
surveil
anim
within
anim
hold
facil
reveal
antibodi
rang
pathogen
includ
coronaviru
theiler
viru
consid
unlik
either
deterg
action
viral
activ
respons
demyelin
possibl
lp
may
directli
toxic
oligodendrocyt
perhap
act
via
plasmalemm
receptor
direct
cell
damag
suggest
studi
demonstr
detriment
effect
lp
surviv
oligodendrocyt
progenitor
vitro
molinaholgado
et
al
howev
mrna
lp
receptor
either
absent
tolllik
receptor
found
low
level
oligodendrocyt
precursor
lehnardt
et
al
hand
mani
commerci
prepar
lp
shown
contain
contamin
highli
bioactiv
activ
receptor
includ
tolllik
receptor
hirschfeld
et
al
receptor
report
express
oligodendrocyt
bsibsi
et
al
contamin
perhap
best
illustr
abil
prepar
activ
leucocyt
mice
lack
function
morrison
et
al
examin
possibl
typic
lp
prepar
inde
act
via
receptor
also
examin
effect
lp
prepar
activ
cell
mice
lesion
result
inject
fig
appear
similar
produc
less
pure
lp
prepar
indic
lesion
result
lp
expect
probabl
mediat
activ
thu
absent
adult
oligodendrocyt
would
unlik
respond
directli
lp
sinc
receptor
thought
play
key
role
signal
transduct
follow
lp
bind
poltorak
et
al
hoshino
et
al
consider
suggest
lp
may
act
via
indirect
mechan
appar
conflict
find
molinaholgado
et
al
indic
oligodendrocyt
progenitor
sensit
lp
seem
absenc
appropri
receptor
demonstr
lehnardt
et
al
probabl
due
degre
cellular
puriti
examin
cultur
lehnardt
colleagu
found
deleteri
effect
lp
oligodendrocyt
progenitor
depend
presenc
microglia
lehnardt
et
al
role
cell
also
support
observ
condit
media
lpsexpos
microglia
astrocyt
injur
oligodendrocyt
progenitor
pang
et
al
factor
respons
clear
role
tnfa
possibl
sinc
cytokin
shown
damag
rodent
selmaj
rain
cammer
human
jurewicz
et
al
oligodendrocyt
vitro
howev
inject
tnfa
white
matter
vivo
result
demyelin
hall
et
al
agent
involv
may
act
concert
factor
perhap
demyelin
result
chronic
rather
acut
exposur
tnfa
recent
evid
suggest
peroxynitrit
form
nitric
oxid
superoxid
anion
play
key
role
lpsinduc
microglialmedi
oligodendrocyt
damag
vitro
li
et
al
thu
although
lp
might
directli
toxic
oligodendrocyt
could
caus
demyelin
indirectli
via
factor
deriv
activ
microglia
astrocyt
macrophag
argu
possibl
fact
dexamethason
treatment
reduc
inflammatori
respons
indic
reduct
cell
express
ino
yet
demyelin
least
extens
seen
control
anim
dexamethason
known
inhibit
lpsinduc
activ
transcript
factor
nuclear
factorkb
activ
monocyt
cell
lead
decreas
product
inflammatori
mediat
jeon
et
al
sever
possibl
explan
dexamethason
reduc
extent
demyelin
first
dexamethason
treatment
may
adequ
suppress
inflamm
may
case
sinc
ino
activ
suppress
elimin
lesion
secondli
cellular
action
lp
dexamethason
complex
activ
cell
lp
via
pathway
unaffect
dexamethason
may
also
occur
perhap
via
cascad
follow
activ
review
see
akira
takeda
certainli
dexamethason
recent
shown
actual
enhanc
express
tissu
factor
reddi
et
al
transmembran
glycoprotein
present
monocyt
cell
activ
coagul
cascad
local
activ
tissu
factor
might
result
ischaemia
therebi
augment
lesion
summari
although
mechan
lpsinduc
demyelin
known
favour
idea
oligodendrocyt
kill
factor
factor
produc
activ
inflammatori
cell
particularli
light
find
lpsactiv
microglia
capabl
induc
oligodendrocyt
damag
cultur
lehnardt
et
al
could
current
observ
lpsinduc
demyelin
illumin
mechan
involv
demyelin
observ
inflammatori
demyelin
diseas
cn
demyelin
occur
associ
inflamm
number
disord
includ
multipl
sclerosi
lassmann
devic
neuromyel
optica
baudoin
et
al
recurr
transvers
myeliti
pandit
rao
associ
tropic
spastic
paraparesi
ijichi
et
al
acut
dissemin
encephalomyel
stuve
zamvil
includ
form
latter
disord
associ
infect
gramneg
bacterium
chlamydia
pneumonia
heick
skriver
howev
understand
mechan
demyelin
disord
often
incomplet
possibl
mechan
involv
one
disord
may
common
oper
current
experiment
lesion
current
lesion
could
act
use
model
explor
mechan
potenti
therapeut
target
note
particular
current
lesion
mag
lost
myelin
protein
loss
appear
occur
prior
initi
demyelin
preferenti
loss
mag
also
occur
inflammatori
demyelin
lesion
multipl
sclerosi
design
pattern
iii
lucchinetti
colleagu
lucchinetti
et
al
aboulenein
et
al
unusu
initi
demyelin
periaxon
myelin
may
anoth
manifest
earli
mag
loss
mag
normal
found
periaxon
myelin
cn
trapp
et
al
pattern
demyelin
reproduc
usual
experiment
model
multipl
sclerosi
name
eae
lucchinetti
et
al
notabl
multipl
sclerosi
h
lassmann
person
commun
current
lp
model
unusu
pattern
demyelin
occur
conjunct
microgli
activ
promin
express
ino
current
find
suggest
lpsinduc
demyelin
might
use
experiment
model
demyelin
lesion
exhibit
pattern
iii
phenotyp
also
interest
determin
whether
demyelin
observ
occur
mechan
similar
respons
produc
lesion
recent
describ
earli
multipl
sclerosi
lesion
barnett
prinea
certainli
lesion
exhibit
promin
oligodendrocyt
loss
vesicular
demyelin
occur
absenc
local
notic
infiltr
lymphocyt
furthermor
neither
lesion
demyelin
appear
depend
upon
myelin
strip
phagocyt
